GB1356076A - Attenuated viruses - Google Patents
Attenuated virusesInfo
- Publication number
- GB1356076A GB1356076A GB5672372A GB5672372A GB1356076A GB 1356076 A GB1356076 A GB 1356076A GB 5672372 A GB5672372 A GB 5672372A GB 5672372 A GB5672372 A GB 5672372A GB 1356076 A GB1356076 A GB 1356076A
- Authority
- GB
- United Kingdom
- Prior art keywords
- virus
- attenuated
- cattle
- dec
- diluent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 241000700605 Viruses Species 0.000 title abstract 6
- 230000002238 attenuated effect Effects 0.000 title abstract 4
- 241000283690 Bos taurus Species 0.000 abstract 2
- 208000010201 Exanthema Diseases 0.000 abstract 2
- 239000003085 diluting agent Substances 0.000 abstract 2
- 201000005884 exanthem Diseases 0.000 abstract 2
- 206010037844 rash Diseases 0.000 abstract 2
- 102000014150 Interferons Human genes 0.000 abstract 1
- 108010050904 Interferons Proteins 0.000 abstract 1
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 abstract 1
- 241000282887 Suidae Species 0.000 abstract 1
- 241000710959 Venezuelan equine encephalitis virus Species 0.000 abstract 1
- 239000007853 buffer solution Substances 0.000 abstract 1
- 244000309466 calf Species 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000016396 cytokine production Effects 0.000 abstract 1
- 239000008298 dragée Substances 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 229940079322 interferon Drugs 0.000 abstract 1
- 238000010255 intramuscular injection Methods 0.000 abstract 1
- 239000007927 intramuscular injection Substances 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000007922 nasal spray Substances 0.000 abstract 1
- 239000006218 nasal suppository Substances 0.000 abstract 1
- 239000006187 pill Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 230000002381 testicular Effects 0.000 abstract 1
- 241000712461 unidentified influenza virus Species 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 208000010484 vulvovaginitis Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16732—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16761—Methods of inactivation or attenuation
- C12N2710/16764—Methods of inactivation or attenuation by serial passage
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2161344A DE2161344C3 (de) | 1971-12-10 | 1971-12-10 | Herstellung von Virusstämmen, welche die natürlichen Abwehrmechanismen eines Wirtsorganismus stimulieren, ohne dabei gleichzeitig antigen zu wirken und Arzneimittel zur Prophylaxe und Behandlung von viralen und bakteriellen Infektionen des Menschen und der Tiere, einen solchen Virusstamm enthaltend |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1356076A true GB1356076A (en) | 1974-06-12 |
Family
ID=5827622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB5672372A Expired GB1356076A (en) | 1971-12-10 | 1972-12-08 | Attenuated viruses |
Country Status (22)
| Country | Link |
|---|---|
| JP (2) | JPS5924137B2 (cg-RX-API-DMAC7.html) |
| AR (1) | AR204075A1 (cg-RX-API-DMAC7.html) |
| AT (1) | AT326817B (cg-RX-API-DMAC7.html) |
| AU (1) | AU473209B2 (cg-RX-API-DMAC7.html) |
| BE (1) | BE792484A (cg-RX-API-DMAC7.html) |
| BG (1) | BG21417A3 (cg-RX-API-DMAC7.html) |
| CA (1) | CA988848A (cg-RX-API-DMAC7.html) |
| CH (1) | CH577558A5 (cg-RX-API-DMAC7.html) |
| CS (1) | CS189587B2 (cg-RX-API-DMAC7.html) |
| DD (1) | DD108115A5 (cg-RX-API-DMAC7.html) |
| DE (1) | DE2161344C3 (cg-RX-API-DMAC7.html) |
| DK (1) | DK143201C (cg-RX-API-DMAC7.html) |
| ES (1) | ES409464A1 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2162637B1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB1356076A (cg-RX-API-DMAC7.html) |
| HU (1) | HU167086B (cg-RX-API-DMAC7.html) |
| IE (1) | IE36995B1 (cg-RX-API-DMAC7.html) |
| NL (1) | NL178014C (cg-RX-API-DMAC7.html) |
| PH (1) | PH12597A (cg-RX-API-DMAC7.html) |
| SE (1) | SE8400283L (cg-RX-API-DMAC7.html) |
| SU (1) | SU439956A3 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA728709B (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0063657A1 (en) * | 1981-04-29 | 1982-11-03 | Merck & Co. Inc. | Topical application of interferon inducers |
-
0
- BE BE792484D patent/BE792484A/xx not_active IP Right Cessation
-
1971
- 1971-12-10 DE DE2161344A patent/DE2161344C3/de not_active Expired
-
1972
- 1972-01-01 AR AR245553A patent/AR204075A1/es active
- 1972-12-01 PH PH14135A patent/PH12597A/en unknown
- 1972-12-02 SU SU1853618A patent/SU439956A3/ru active
- 1972-12-05 JP JP47121264A patent/JPS5924137B2/ja not_active Expired
- 1972-12-05 JP JP47121265A patent/JPS6011013B2/ja not_active Expired
- 1972-12-06 BG BG022052A patent/BG21417A3/xx unknown
- 1972-12-07 CS CS728391A patent/CS189587B2/cs unknown
- 1972-12-07 NL NLAANVRAGE7216628,A patent/NL178014C/xx not_active IP Right Cessation
- 1972-12-07 AT AT1041972A patent/AT326817B/de not_active IP Right Cessation
- 1972-12-08 CA CA158,535A patent/CA988848A/en not_active Expired
- 1972-12-08 GB GB5672372A patent/GB1356076A/en not_active Expired
- 1972-12-08 IE IE1716/72A patent/IE36995B1/xx unknown
- 1972-12-08 DD DD167455A patent/DD108115A5/xx unknown
- 1972-12-08 ZA ZA728709A patent/ZA728709B/xx unknown
- 1972-12-08 HU HUBA2833A patent/HU167086B/hu unknown
- 1972-12-08 FR FR7243868A patent/FR2162637B1/fr not_active Expired
- 1972-12-08 DK DK615472A patent/DK143201C/da not_active IP Right Cessation
- 1972-12-08 CH CH1791372A patent/CH577558A5/xx not_active IP Right Cessation
- 1972-12-09 ES ES409464A patent/ES409464A1/es not_active Expired
- 1972-12-11 AU AU49920/72A patent/AU473209B2/en not_active Expired
-
1984
- 1984-01-20 SE SE8400283A patent/SE8400283L/sv not_active Application Discontinuation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0063657A1 (en) * | 1981-04-29 | 1982-11-03 | Merck & Co. Inc. | Topical application of interferon inducers |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE36995L (en) | Producing attenuated viruses. | |
| FR1512339A (fr) | Procédé de préparation de produits céramiques ayant un faible coefficient de dilatation | |
| GB1169930A (en) | Improvements in or relating to Lactam Salts | |
| FR849987A (fr) | Procédé pour préparer des produits d'interpolymérisation analogues au caoutchouc | |
| GB1444968A (en) | Manufacture of t-butanol | |
| USD134664S (en) | Combination bottle cap opener and bricklayer s line pin | |
| FR914535A (fr) | Procédé de préparation des interpolymères d'éthylène avec les esters vinyliques et produits en résultant | |
| USD140747S (en) | Glass candle holder or article of similar nature | |
| USD130688S (en) | Design for a cooking range | |
| GB625646A (en) | Improvements in or relating to processes for manufacturing mercaptans and the products thereof | |
| FR1331287A (fr) | Procédé d'épuration des lessives de soude, produits épurés par le présent procédé ou procédé similaire | |
| GB1390650A (en) | Oxazines and thiazines | |
| GB1413401A (en) | Influenza vaccine | |
| ES347230A1 (es) | Procedimiento para preparar carbonatos de 3-oxo - 17-beta- hidroxiestra-4, 9, 11-trieno. | |
| GB1274032A (en) | NOVEL 1-OXA-17alpha-METHYL-A-NOR-GONA-3,9-DIEN-2-ONES, PROCESSES FOR THEIR PREPARATION, AND COMPOSITIONS INCORPORATING THEM | |
| TAHAMA | Studies on the dwarf disease of mulberry tree (X) Further experiments on the transmission by leafhopper, Hishimonus disciguttus Walker.-1 | |
| GB942868A (en) | Preparing triethylenediamine | |
| ES248501A1 (es) | Procedimiento de fabricaciën del magnesio | |
| GB668861A (en) | Improvements in or relating to the transfer of granular materials | |
| FR1326925A (fr) | Procédé de séparation des produits de réaction de l'eau, du trifluorure de bore et d'un oxyde minéral modifié par ce trifluorure d'avec un hydrocarbure liquide contenant ces produits | |
| GB1330950A (en) | Synthesis of 1,2-bis-p-carboxyphenoxy ethane | |
| Vengerovsky | Osteomyelitis of the ilium in children | |
| GB1336949A (en) | Adenosine derivatives | |
| FR917178A (fr) | Procédé et installation d'extraction, par des liquides, de produits en dissolution | |
| ES291803A1 (es) | Procedimiento de fabricaciën del beta-(neftil) -1) beta'tetrahidrofuril isobutirato de n-dietilaminoetilo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PCNP | Patent ceased through non-payment of renewal fee |